|
TMEM70 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.83299997402742E-09 |
| Normal-vs-Stage3 |
1.26787469412193E-13 |
| Normal-vs-Stage4 |
1.62492241884138E-12 |
| Stage1-vs-Stage2 |
5.776600E-01 |
| Stage1-vs-Stage3 |
2.573400E-01 |
| Stage1-vs-Stage4 |
8.425900E-02 |
| Stage2-vs-Stage3 |
8.892000E-01 |
| Stage2-vs-Stage4 |
9.991900E-02 |
| Stage3-vs-Stage4 |
2.725800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.96613861145079E-12 |
| Normal-vs-Asian |
2.92219581865538E-11 |
| Caucasian-vs-AfricanAmerican |
4.823800E-01 |
| Caucasian-vs-Asian |
7.229400E-01 |
| AfricanAmerican-vs-Asian |
4.601000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.99520433297585E-15 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.811200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.9471091405876E-12 |
| Normal-vs-Age(81-100Yrs) |
1.151410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.402000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.639200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.836600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.202800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.983200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.187600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.527800E-01 |
| Classical-VS-Follicular |
4.676400E-01 |
| Classical-VS-Other |
3.744600E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.911000E-01 |
| Tall-VS-Other |
2.403600E-01 |
| Tall-VS-Normal |
2.77440004303742E-09 |
| Follicular-VS-Other |
6.585400E-01 |
| Follicular-VS-Normal |
1.91158200379959E-12 |
| Other-VS-Normal |
2.33009999999201E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
4.44089209850063E-16 |
| N0-vs-N1 |
7.697800E-02 |
|
|
